EMA-CO Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of etoposide, high-dose methotrexate and dactinomycin (Actinomycin-D), followed by cyclophosphamide and vincristine, used for the treatment of metastatic gestational trophoblastic tumors (GTT).

**Synonyms:** - Actinomycin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine - Cyclophosphamide/Dactinomycin/Etoposide/Methotrexate/Vincristine - EMA-CO - EMA-CO - EMA/CO Regimen - EMACO - Etoposide-Methotrexate-Actinomycin-D-Cyclophosphamide-Oncovin Regimen - Etoposide/Methotrexate/Actinomycin D/Cyclophosphamide/Vincristine Regimen - Etoposide/Methotrexate/Actinomycin-D/Cyclophosphamide/Vincristine Regimen